DR. HUGH BRANDON PERKIN M.D. NPI 1801066063

NPI Details

DR. Hugh Brandon Perkin, M.D. is an urology in Templeton, CA with 21 years of experience. The provider is a urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures. DR. Hugh Brandon Perkin, M.D. NPI is 1801066063. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE
Graduation Year:2005

The provider's business location address is:

1310 LAS TABLAS RD
SUITE 201
TEMPLETON, CA
ZIP 93465-737
Phone: (805) 786-2500
Fax: (805) 781-0423

The NPI 1801066063 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, testosterone undecanoate, 1 mg (HCPCS:J3145)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, onabotulinumtoxina, 1 unit (HCPCS:J0585)
• Bcg live intravesical instillation, 1 mg (HCPCS:J9030)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Automated urinalysis test (HCPCS:81003)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Diagnostic exam of bladder and urethra using an endoscope (HCPCS:52000)
• Unclassified drugs (HCPCS:J3490)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Ultrasound measurement of bladder capacity after voiding (HCPCS:51798)
• Ultrasonic guidance for needle placement (HCPCS:76942)
• Insertion of lower leg neurostimulator electrode (HCPCS:64566)
• Biopsy of prostate gland (HCPCS:55700)
• Simple insertion of temporary bladder tube (HCPCS:51702)
• Instillation of anti-cancer drug into bladder (HCPCS:51720)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• Tissue marker, implantable, any type, each (HCPCS:A4648)
• Simple bladder irrigation and/or instillation (HCPCS:51700)
• Simple change of bladder tube (HCPCS:51705)
• Shock wave crushing of kidney stones (HCPCS:50590)
• Insertion of device into abdomen with pressure and urine flow rate study (HCPCS:51797)
• Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope (HCPCS:52601)
• Electronic assessment of bladder emptying (HCPCS:51741)
• Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings (HCPCS:51784)
• Placement of hormone pellet under skin (HCPCS:11980)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Exam with injections of chemical for destruction of bladder using an endoscope (HCPCS:52287)
• Imaging of urinary tract following injection of a contrast agent (HCPCS:74420)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
• Destruction and/or removal of large growth of bladder using an endoscope (HCPCS:52240)
• Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies (HCPCS:51729)
• Placement of device in prostate for radiation therapy (HCPCS:55876)
• Injection of biodegradable material next to prostate (HCPCS:55874)
• Crushing of stone of ureter with insertion of stent using an endoscope (HCPCS:52356)
• Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm (HCPCS:52235)
• Complex measurement of pressure of urine flow in bladder with voiding pressure studies (HCPCS:51728)
• Removal of stent in ureter through ureter with review by radiologist (HCPCS:50386)
• Insertion of temporary bladder tube (HCPCS:51701)
• Prostate resection (HCPCS:NAN14)

The enumeration date for this NPI number is 3/4/2008 and was last updated on 4/22/2015.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.